Safety and Efficacy of Diacerein 1% Ointment for Subjects With Epidermolysis Bullosa Simplex (EBS)
Clinical trial NCT03154333 · TERMINATED
Trial details
- NCT number
- NCT03154333
- Sponsor
- Castle Creek Pharmaceuticals, LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-01
- Primary completion
- 2018-10-15
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.